Celiac Disease Market Growth Expected to Reach US$ 1,362.1 Million by 2034

The Celiac Disease Market is expected to witness significant growth in the coming years, with the market reaching a value of US$ 1,362.1 Million by 2034, showing a growth rate (CAGR) of 9.85% during 2023-2034. Enzyme supplements like lactase and alpha-galactosidase are being widely used to improve digestion and reduce symptoms of bloating and gas, further fueling market growth. Key players in the industry are investing heavily in exploring microbial therapies like fecal microbiota transplantation (FMT) and probiotics to alter the gut microbiome and alleviate inflammation in the intestine, which is driving market expansion. The adoption of gluten-detoxification therapies and the increasing use of non-invasive methods for diagnosing celiac disease using saliva are expected to propel market growth in the forecast period.